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Abstract
Background: Genetic polymorphisms in the gene encoding the b-adrenergic receptors (b-AR) have a pivotal role in the
functions of the autonomic nervous system. Using heart rate variability (HRV) as an indicator of autonomic function, we
present a bottom-up genotype–phenotype analysis to investigate the association between b-AR gene polymorphisms and
heart rate dynamics.
Methods: A total of 221 healthy Han Chinese adults (59 males and 162 females, aged 33.6610.8 years, range 19 to 63 years)
were recruited and genotyped for three common b-AR polymorphisms: b1-AR Ser49Gly, b2-AR Arg16Gly and b2-AR
Gln27Glu. Each subject underwent two hours of electrocardiogram monitoring at rest. We applied an information-based
similarity (IBS) index to measure the pairwise dissimilarity of heart rate dynamics among study subjects.
Results: With the aid of agglomerative hierarchical cluster analysis, we categorized subjects into major clusters, which were
found to have significantly different distributions of b2-AR Arg16Gly genotype. Furthermore, the non-randomness index, a
nonlinear HRV measure derived from the IBS method, was significantly lower in Arg16 homozygotes than in Gly16 carriers.
The non-randomness index was negatively correlated with parasympathetic-related HRV variables and positively correlated
with those HRV indices reflecting a sympathovagal shift toward sympathetic activity.
Conclusions: We demonstrate a bottom-up categorization approach combining the IBS method and hierarchical cluster
analysis to detect subgroups of subjects with HRV phenotypes associated with b-AR polymorphisms. Our results provide
evidence that b2-AR polymorphisms are significantly associated with the acceleration/deceleration pattern of heart rate
oscillation, reflecting the underlying mode of autonomic nervous system control.
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Introduction
Instantaneous heart rate in response to physiological perturba-
tions often exhibits remarkable oscillations at multiple time scales.
These oscillations, known as heart rate variability (HRV), are
mainly mediated by the autonomic nervous system via parasym-
pathetic and sympathetic innervations. Analysis of HRV has been
suggested to reveal subtle patterns of heart rate dynamics that are
relevant to the underlying physiological state and autonomic
nervous system function [1]. Prior studies have shown that HRV
measures are highly heritable traits that can be used to support
genetic association and linkage studies [2,3,4,5]. Family and twin
studies have shown a significant genetic influence on a variety of
HRV measures [6,7]. Genetic polymorphisms related to cardio-
vascular functions have been associated with altered HRV
[8,9,10,11]. Recently, we have also made progress in identifying
variations in two genes related to neuropsychiatric function that
are associated with altered heart rate dynamics in samples of
healthy adult and elderly subjects: those encoding brain-derived
neurotrophic factor (BDNF) [12] and apolipoprotein E [13],
respectively.
Despite increasing focus on investigating the genetic influence
on autonomic functions, current approaches to genotype–HRV
associations have largely been characterized by a top-down
approach involving a direct comparison of continuous HRV
variables among pre-defined groups of subjects (i.e., healthy vs. ill
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genetic polymorphism may determine a similar pattern of
autonomic heart rate control from one subject to another.
Specifically, heart rate dynamics is a phenotypic ‘‘expression’’ of
the autonomic nervous system, so comparing similar heart rate
oscillation phenotypes among individuals may reveal a global
profile of autonomic function relevant to genetic variants. With
these considerations in mind, in the present study, we introduce a
bottom-up genotype–phenotype analysis to investigate the associ-
ation between genetic polymorphisms and autonomic control of
heart rate dynamics, using three common polymorphisms in genes
encoding b-adrenergic receptor (b-AR) as an example.
b-AR has a pivotal role in the functions of the cardiac autonomic
nervous system. Activation of b1-AR provides strong stimulus to
increase the frequency and contractility of the heart, whereas the
activation of b2-AR results in smooth muscle relaxation and
increased cardiac output with less extent compared to b1-AR.
Thus, the connection between b-AR and HRV is plausible and
warrants evaluations. Limited evidences suggest that variations in
genes coding subtypes of b-AR may be associated with heart rate
or HRV. For example, Ser49Gly polymorphism in b1-AR gene
has been found to be associated with resting heart rate [14,15],
and an association of b2-AR gene polymorphisms with spectral
components of HRV measures has been reported in a relatively
small healthy adult male sample [11].
We applied an information-based similarity index (IBS) [16,17]
to measure the pairwise dissimilarity of interbeat interval time
series among a sample of healthy adult volunteers. The IBS
method is based on rank-order frequency analysis of acceleration/
deceleration patterns of heart rate fluctuation. Because stimulus of
b-AR results in acceleration of heart rate, the functional changes in
genetic polymorphisms of b-AR may affect acceleration/deceler-
ation patterns of heart rate, which can be detected by the IBS
method. The analyses of the present study were two-fold: 1) a non-
randomness index [17] derived from the IBS method was applied
to quantify the nonlinear aspect of HRV according to b-AR
genotype and to test the correlation of this index with standard
HRV indices; and 2) using agglomerative hierarchical cluster
analysis, we unsupervisedly categorized these subjects into clusters
based on pairwise dissimilarity among heart rate dynamics, and
then we investigated the association of these clustering patterns
with b-AR gene polymorphisms. We show that this bottom-up,
categorization approach combining the IBS method and hierar-
chical cluster analysis can detect subgroups of subjects based on
phenotypes that are associated with b-AR gene polymorphisms.
Materials and Methods
Subjects
Two hundred forty-seven healthy Han Chinese adult volunteers
were recruited from two medical centers: Taipei Veterans General
Hospital and Kaohsiung E-DA Hospital, Taiwan. Subjects were
recruited by advertisement among medical employees, research
laboratory staff working at both hospitals, and their relatives. All
subjects gave informed consent before commencement of the
study. The protocol was approved by the institutional review
boards of the Taipei Veterans General Hospital (Taipei, Taiwan)
and E-DA Hospital (Kaohsiung, Taiwan). Each subject was given
an interview using a standard questionnaire to carefully review the
history of medical disease, psychiatric illness, and medication use.
Subjects included in the study did not have a personal history of
medical conditions (e.g., malignant tumors, heart failure, or
diabetes mellitus), pregnancy, psychiatric illnesses or substance
abuse/dependence. None of the subjects was taking any
medication. The collected demographic data included age, sex,
body mass index, and smoking. Of note, most volunteers were
hospital colleagues, and the rate of smoking was low (n=2, 0.9%).
Of these subjects, 228 were successfully contacted for ambula-
tory electrocardiogram (ECG) monitoring. Holter recordings
(MyECG E3-80 Portable Recorder, Microstar Inc., Taipei,
Taiwan) were used to obtain two hours of ECG signals. The E3-
80 device continuously recorded three channels of ECG signals at
a sampling rate of 250 Hz. All ECG monitoring took place in the
daytime, and participants were asked to avoid smoking or drinking
alcoholic beverages and to stay in a resting state while being
monitored. Valid DNA samples were obtained in 221 subjects by
drawing blood or by buccal swabs. The final study sample
therefore consisted of 221 healthy adult subjects (59 males and 162
females, aged 33.6610.8 years, range 19–63 years). Among the
present study sample, 211 subjects have been included elsewhere
in a previous report on the altered sympathovagal balance
associated with Val66Met polymorphisms of the BDNF gene [12].
Genotyping
Each subject was genotyped for three polymorphisms
(rs1801252, rs1042713 and rs1042714), and genomic DNA was
isolated using the PUREGENE DNA purification system (Gentra
Systems, Minneapolis, MN, USA). The genotypes of rs1042713
were determined using polymerase chain reaction and restriction
fragment length polymorphism analysis. Briefly, primers and
probes were designed with SpectroDESIGNER software (Seque-
nom, San Diego, CA, USA). PCR was then performed, and
unincorporated double-stranded nucleotide triphosphate bases
(dNTPs) were dephosphorylated with shrimp alkaline phosphatase
(Hoffman-LaRoche, Basel, Switzerland) followed by primer
extension. The purified primer extension reaction product was
spotted on to a 384-element silicon chip (SpectroCHIP, Seque-
nom) and analyzed in a Bruker Biflex III MALDI-TOF Spectro-
READER mass spectrometer (Sequenom). The resulting spectra
were then processed with SpectroTYPER (Sequenom). All samples
were genotyped for eight unrelated SNPs for DNA quality
examination. The samples were diluted onto 96-well plates, and
only the plates on which each of the eight unrelated SNPs had a
successful genotyping rate greater than 95% were used for further
study. All experiments were performed by investigators who were
blind to phenotype. Failure in genotyping for rs1801252
polymorphism was noted in 6 cases.
Analysis of heart rate variability
The ECG signals were automatically processed and analyzed by
open-source HRV algorithms [18]. The standard HRV analysis
has been well reviewed [19]. Briefly, time domain measures of
HRV include the mean heart rate and standard deviation of the
normal interbeat intervals (SDNN), the root mean square
successive difference between adjacent normal interbeat intervals
(RMSSD), and the percentage of adjacent intervals that varied by
greater than 50 ms (pNN50) [20]. The SDNN assesses the overall
variability of interbeat intervals. The RMSSD and pNN50
measure the short-term variation of interbeat intervals, which is
mainly modulated by parasympathetic innervation [21]. Standard
spectral HRV measures [19] include high-frequency power (HF;
0.15–0.40 Hz), low-frequency power (LF; 0.04–0.15 Hz), and very
low-frequency power (VLF; 0.003–0.04 Hz). LF power is
suggested to be modulated by both sympathetic and parasympa-
thetic activities, whereas HF power is mainly modulated by
parasympathetic activity [22,23]. The LF/HF ratio is considered a
measure of the shift of sympathovagal balance toward sympathetic
activity [19,24]. The physiological mechanism underlying VLF
Clustering Heart Rate Dynamics
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the renin–angiotensin–aldosterone system or parasympathetic
modulation [19,25,26].
In addition, we incorporated two nonlinear HRV indices:
detrended fluctuation analysis (DFA) [27,28] and multiscale
entropy (MSE) [29]. DFA quantifies the presence of long-range
(fractal) correlations whereas MSE measures the entropy over
multiple time scales inherent in physiologic signals and is therefore
a complexity measure. Both methods are available at Physionet
(http://physionet.org), a research resource for complex physio-
logic signals [18].
In the DFA method, the root-mean-square fluctuation of
integrated and detrended time series is measured at different
observation windows and plotted against the size of the
observation window on a log-log scale. The scaling exponent a
is then derived from the slope of line fitting to the obtained log-log
plot. The short-term exponent a1 (4 to 11 heartbeats) and the long-
term scaling exponents a2 (.11 heartbeats) were also calculated
[27,30,31]. Low-exponent values represent reduced fractal proper-
tiy of heart rate dynamics and have been implicated in the risk of
fatal cardiac arrhythmia, increased mortality, or poor prognosis in
cardiovascular diseases [32,33,34,35].
MSE has been proposed as a biologically meaningful complex-
ity measure by quantifying the entropy over multiple time scales
inherent in physiologic signals. The procedure and calculation of
the MSE is summerized as following three steps: 1) construction of
coarse-grained time series, 2) quantification of the sample entropy
of each coarse-grained time series, and 3) summation of the sample
entropy values over a range of scales. In the present study, sample
entropy was calculated using a pattern length (m) of 2 and a
similarity factor (r) of 0.15. The sum of sample entropy over all
scale factors from 1 to 20 was computed to represent the overall
MSE measure. In addition, the sum of sample entropy over scale
factors from 1–5 and 6–20 was calculated to represent short-term
and long-term MSE measures, respectively [36].
Analysis of information-based similarity index
Several methods of symbolic dynamic analysis of HRV have
been proposed previously [37,38,39,40,41]. The IBS method was
developed to effectively categorize symbolic sequences according
to their information content. The method has been fully described
and validated [16], with applications to heart rate time series,
literary texts, and genetic sequences [17,42,43].
An interbeat interval time series (or heart rate time series) is
mapped to a symbolic sequence, according to a mapping rule that
accelerated heart rate in consecutive heartbeats is designated as 0
and a deceleration of heart rate is designated as 1 (Figure 1A). This
way of mapping captures the essential dynamics of the autonomic
nervous system’s control of heart rate and is less sensitive to noisy
fluctuations in interbeat interval time series commonly caused by
ectopic heartbeats [17]. A binary, symbolic ‘‘word’’ is then defined
as a n-tuple sequence derived from n+1 consecutive interbeat
intervals. We determined the frequencies of each pattern of n-tuple
sequences by applying a sliding window (moving one interbeat
interval/step) across the entire interbeat interval time series and
then ranked each n-tuple sequence according to its frequency in
descending order.
To compare the similarity between symbolic sequences, we
plotted the rank number of each n-tuple sequence in the first
sequence against that of the second sequence (Figure 1B). If two
sequences are similar in their rank order of n-tuples, the scattered
points will be located near the diagonal line (e.g., comparison
between healthy subjects) [17]. Therefore, the average deviation of
these scattered points away from the diagonal line is a measure of
the dissimilarity index between these two sequences.
We defined the distance (Dn) using n-tuples between two
sequences, S1 and S2,a s
Dn(S1,S2)~
1
N{1
X N
k~1
R1(wk){R2(wk) jj
H1(wk)zH2(wk)
P N
k~1
H1(wk)zH2(wk) ½ 
Here R1(wk) and R2(wk) represent the rank of a specific n-tuple,
wk, in sequences S1 and S2, respectively. N=2
n is the number of
different n-tuple sequences (or patterns). The absolute difference of
Figure 1. Schematic illustration of the information-based
similarity index method. (A) The mapping procedure for a n-tuple
binary symbolic sequence (here n=6 for illustrative purposes) from part
of an interbeat interval time series. (B) Rank-order comparison of two
interbeat interval time series from the two healthy subjects, using 6-
tuple binary symbolic mapping. In this case, frequencies of 2
6=64 6-
tuple symbolic patterns were determined and ranked accordingly. For
each 6-tuple symbolic sequence (black dot), its rank in subject A is
plotted against its rank in subject B. The dashed diagonal line indicates
the case where the rank order of 6-tuple symbolic sequence for both
subjects is identical.
doi:10.1371/journal.pone.0019232.g001
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entropy H for wk in sequences S1 and S2 [44]. Shannon’s entropy
measures the information richness of each n-tuple in both
sequences. Thus, the more frequently used n-tuples contribute
more to measuring similarity among symbolic sequences. Of note,
the IBS is an empirical index which does not necessarily obey the
triangular inequality criterion of a distance measure. Therefore,
the triangular inequality test is required before generating a cluster
[16,17]. The IBS algorithm was available at Physionet (http://
www.physionet.org/physiotools/ibs/).
The applications of the IBS method in the present study were
two-fold: 1) The pairwise distance of heart rate dynamics among
individuals was calculated by an average of IBS distance using n-
tuple symbolic sequences (n=2–10) and was used in subsequent
hierarchical cluster analysis. 2) To quantify the nonlinear aspect of
heart rate time series, a non-randomness index was defined to
measure the symbolic patterns of heart rate dynamics away from
complete randomness (i.e., absence of ordered control of the
autonomic nervous system) [17]. The non-randomness index is
independent of conventional entropic measures (i.e., sample
entropy or approximate entropy) and has been evaluated in other
studies [17,45,46,47]. The calculation of the non-randomness
index is based on estimating the average n-tuple distance between
raw interbeat interval time series and its randomly shuffled
surrogates using the IBS method, where the number of surrogates
was 100 in the present study. The averaged non-randomness index
derived from each n-tuple non-randomness index (n=2–10) was
then used in this study for comparisons among b-AR genotypes.
Statistical analysis
We calculated allele and genotype frequencies and performed
Hardy–Weinberg equilibrium tests for each b-AR genotype. The
spectral HRV indices were log-transformed to produce normal-
ized distributions. To control for the effects of non-genetic factors,
differences in HRV variables were compared for individual
genotypes using a general linear model (GLM) followed by the
Bonferroni post hoc test for corrections of multiple between-group
comparisons., using age, gender, and body mass index as
covariates. Effect sizes were calculated with Cohen d, defined as
the difference between the means of two groups, divided by the
pooled standard deviation of these groups. Partial correlation
analysis was applied, controlling for age and BMI, to determine
the associations between standard HRV indices and non-
randomness index derived from the IBS method. A p value
of less than 0.05 (two-tailed) was required for all statistical
comparisons.
A complete-linkage, hierarchical clustering tree was estimated
using the generalized association plot (GAP) (http://gap.stat.
sinica.edu.tw/). GAP is implemented here as an unsupervised
clustering algorithm to visually categorize all subjects based on the
dissimilarity matrix, which is derived from calculating the pairwise
dissimilarity of heart rate dynamics among subjects using the IBS
method. Cluster-specific association was analyzed by the chi-
square test to assess the frequency of b-AR polymorphisms and by
the GLM model to test the differences in standard HRV indices
among resulting clusters. To validate cluster-specific associations,
we tested the differences in HRV and b-AR genotypes in estimated
clusters based on first- and second-half ECG data.
Results
Demographic data
Demographic and clinical data for subjects with each b-AR
genotype are presented in Table S1 and S2. The subgroups in
three genotypes did not differ in age, gender ratio, smoking status,
or body mass index. There was no detectable deviation from
Hardy–Weinberg equilibrium in b1-AR Ser49Gly genotype
(x
2=0.169, P=0.681), b2-AR Arg16Gly genotype (x
2=0.824,
P=0.364) or b2-AR Gln27Glu genotype (x
2=2.188, P=0.139).
Association of b-AR genotypes with standard heart rate
variability
Tables 1, 2, 3 summarize the association of b-AR genotypes with
HRV indices determined by a GLM model using age, gender, and
BMI as covariates. There was no significant effect of interaction on
HRV indices detected between b-AR genotypes and demographic
variables.
b1-AR Ser49Gly genotype was associated with mean heart rate
and SDNN with borderline significance (Table 1; p=0.087 and
p=0.064, respectively). No statistical association was found
between b2-AR Gln27Glu genotype and HRV indices (Table 2).
For the b2-AR Arg16Gly genotype (Table 3), a significant codo-
minant association was found with LF% (F=3.636, p=0.028)
and the non-randomness index derived from the IBS method
(F=5.642, p=0.004). Multiple comparisons showed that LF%
was significantly lower in homozygous Arg16 carriers compared to
subjects with the Arg16/Gly16 genotype (p=0.016), but not to
homozygous Gly16 carriers (p=0.985). Likewise, a significantly
lower non-randomness index was found in homozygous carriers of
the Arg16 allele (p=0.016) compared to subjects heterozygous for
Arg16/Gly16 (p=0.001), and a borderline significance was seen in
the comparison to homozygous Gly16 carriers (p=0.057).
There was no significant difference in HRV indices between
heterozygotes Arg16/Gly16 and homozygous Gly16 carriers,
Table 1. Heart rate variability profile according to
b1-adrenergic receptor Ser49Gly genotype.
Ser/Ser
n=155
Gly allele
n=60 p
Time domain
Mean heart rate, beats/minute 82.9613.2 86.2612.0 0.087
SDNN, ms 77.3624.4 70.7620.2 0.064
RMSSD, ms 30.6613.5 28.0613.3 0.204
pNN50, % 10.4611.0 9.1610.5 0.448
Frequency domain
VLF power, ln(ms
2/Hz) 8.5660.53 8.4660.61 0.527
LF power, ln(ms
2/Hz) 7.3760.62 7.3260.76 0.580
LF percentage, % 22.066.4 23.067.0 0.345
HF power, ln(ms
2/Hz) 6.4760.84 6.3360.96 0.293
HF percentage, % 10.066.1 9.365.1 0.488
LF/HF ratio, normalized units 3.1661.48 3.5061.94 0.170
Nonlinear domain
Detrended fluctuation analysis, a 0.9060.07 0.9060.07 0.911
Detrended fluctuation analysis, a1 1.2060.18 1.2460.19 0.199
Detrended fluctuation analysis, a2 1.0760.09 1.0660.08 0.493
Multiscale entropy, scale 1–20 28.865.75 29.5665.74 0.397
Multiscale entropy, scale 1–5 6.661.5 6.761.6 0.657
Multiscale entropy, scale 6–20 22.264.4 22.864.4 0.340
Non-randomness, symbolic word length 2–10 0.3260.11 0.3360.11 0.348
Failure in genotyping for b1-AR Ser49Gly polymorphism was noted in 6 cases.
doi:10.1371/journal.pone.0019232.t001
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indices. Thus, when the sample was stratified according to the
presence of the Gly16 allele, a significantly lower non-randomness
index was detected in Arg16 homozygotes compared to subjects
with one or two Gly16 alleles (p=0.001). The effect size of the
non-randomness index among Gly16 and non-Gly16 groups was
0.22 (Cohen d=0.46). The Gly16 and non-Gly16 carriers trended
toward a significant difference in LF% (p=0.069).
Correlations between non-randomness index and
standard heart rate variability
To ascertain the relationship of non-randomness index with
autonomic function, we estimated the partial correlation between
non-randomness index and standard HRV variables, controlling
for age and BMI (Table S3). A weak but significant positive
correlation of the non-randomness index with the LF/HF ratio
was found (r=0.234, p=0.001), whereas negative correlations
were found with RMSSD (r=20.274, p,0.001) and pNN50
(r=20.279, p,0.001).
Association of heart rate dynamic clusters with b-AR
gene polymorphisms
Next, we investigated the b-AR genotype distributions in an
unsupervised cluster tree based on the dissimilarity (distance)
measure of heart rate dynamics. We first estimated the pairwise
distance between interbeat interval time series of all subjects using
the IBS method. No violation of the triangular inequality was
observed. We then applied a hierarchical clustering algorithm to
cluster these subjects based on the obtained distance matrix. Two
major clusters were identified in the resulting dendrogram
(Figure 2). There was no significant difference in age, gender, or
Table 2. Heart rate variability profile according to b2-
adrenergic receptor Gln27Glu genotype.
Gln/Gln
n=181
Glu allele
n=40 p
Time domain
Mean heart rate, beats/minute 83.8613.0 84.0612.8 0.290
SDNN, ms 76.9624.6 71.7618.1 0.207
RMSSD, ms 30.2613.7 29.3613.3 0.698
pNN50, % 10.2611.1 10.3610.9 0.987
Frequency domain
VLF power, ln(ms
2/Hz) 8.5460.58 8.5060.45 0.674
LF power, ln(ms
2/Hz) 7.3660.68 7.3460.63 0.845
LF percentage, % 22.266.6 22.566.5 0.763
HF power, ln(ms
2/Hz) 6.4560.89 6.3960.90 0.728
HF percentage, % 9.866.0 9.865.5 0.763
LF/HF ratio, normalized units 3.2661.65 3.2361.62 0.973
Nonlinear domain
Detrended fluctuation analysis, a 0.9060.07 0.9060.07 0.940
Detrended fluctuation analysis, a1 1.2160.19 1.2260.18 0.749
Detrended fluctuation analysis, a2 1.0760.09 1.0760.09 0.868
Multiscale entropy, scale 1–20 28.765.9 29.865.2 0.283
Multiscale entropy, scale 1–5 6.661.5 6.961.6 0.288
Multiscale entropy, scale 6–20 22.164.5 22.963.9 0.302
Non-randomness, symbolic word length 2–10 0.3260.11 0.3160.11 0.793
doi:10.1371/journal.pone.0019232.t002
Table 3. Heart rate variability profile according to b2-adrenergic receptor Arg16Gly genotype.
Arg16/Arg16
n=78
Arg16/Gly16
n=101
Gly16/Gly16
n=42
P
(codominant)
P
(Gly-dominant)
Time domain
Mean heart rate, beats/minute 83.7614.5 83.8612.0 84.1612.1 0.991 0.947
SDNN, ms 77.4624.9 75.4624.8 74.3617.9 0.756 0.484
RMSSD, ms 31.0614.5 30.1613.3 28.5612.7 0.633 0.470
pNN50, % 11.1612.4 9.9610.3 9.6610.3 0.711 0.416
Frequency domain
VLF power, ln(ms
2/Hz) 8.5460.65 8.5460.51 8.5260.47 0.967 0.891
LF power, ln(ms
2/Hz) 7.3160.74 7.4360.63 7.2760.62 0.284 0.423
LF percentage, % 21.265.9 23.566.9 21.266.4 0.028 0.069
HF power, ln(ms
2/Hz) 6.4260.97 6.5060.82 6.3360.90 0.575 0.818
HF percentage, % 10.067.2 10.065.3 9.164.6 0.702 0.784
LF/HF ratio, normalized units 3.1761.73 3.2861.63 3.3561.52 0.830 0.375
Nonlinear domain
Detrended fluctuation analysis, a 0.9060.07 0.9060.06 0.9160.07 0.237 0.817
Detrended fluctuation analysis, a1 1.1960.19 1.2360.19 1.2060.16 0.237 0.189
Detrended fluctuation analysis, a2 1.0760.09 1.0660.09 1.0960.09 0.222 0.658
Multiscale entropy, scale 1–20 28.565.6 29.565.8 28.266.0 0.363 0.488
Multiscale entropy, scale 1–5 6.561.5 6.861.6 6.461.7 0.287 0.558
Multiscale entropy, scale 6–20 22.064.3 22.764.4 21.864.5 0.421 0.482
Non-randomness, symbolic word length 2–10 0.2960.11 0.3460.11 0.3360.09 0.004 0.001
doi:10.1371/journal.pone.0019232.t003
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shown). Table 4 shows b-AR genotypes and standard HRV
characteristics according to two major clusters. A significant
deviation in the distribution of homozygous b2-AR Arg16 carriers
was detected between the two clusters (p=0.011), whereas the
other genotypes showed no deviation in genotype distribution.
In terms of standard HRV characteristics, cluster 1 (with a
higher rate of homozygous b2-AR Arg16 carriers) showed
significantly reduced LF power (p,0.001) and significantly
increased HF power (p=0.001). The clusters did not differ in
other HRV indices. We verified the genotype distribution with
clusters based on first- and second-half ECG data, and the results
were consistent (Table S4).
Discussion
The data presented in this study demonstrate a significant
association of a common b2-AR polymorphism, Arg16Gly, with
the non-randomness index, a nonlinear HRV measure derived
from the IBS method. Moreover, we illustrate that a bottom-up
approach using the IBS method was able to measure the
dissimilarity of heart rate dynamics among individuals, and we
show that the resulting clusters were associated with b2-AR
Arg16Gly genotype, indicating an impact of this b2-AR polymor-
phism on acceleration/deceleration patterns of heart rate
oscillations.
Our study offers several advantages for studying genetic
associations with physiological parameters and might be general-
izable to other genotype–phenotype studies based on different
types of time series (e.g., brain electroactivity or time series derived
from functional magnetic resonance imaging). First, our method
enables us to cluster heart rate dynamics by an IBS method based
on their acceleration/deceleration patterns of heartbeat sequence.
The IBS method was not exclusively developed for the analysis of
heartbeat sequence but also for other generic datasets consisting of
repetitive elements [42,43]. With an appropriate mapping rule
that is meaningful to a target dataset, the IBS method can be
applied to other types of phenotypic data derived from the time
series [16]. Second, we employed a visually aided hierarchical
analysis by a software tool called a generalized association map,
which enables a bottom-up approach to unsupervisedly identify
heart rate clusters to study genotype–phenotype associations. This
bottom-up approach may help reduce the false-positivity com-
monly seen in conventional association studies.
b1-AR is the predominant b-AR subtype in the heart. Compared
to activation of b2-AR, stimulation in b1-AR can result in more
Figure 2. Unsupervised, hierarchical cluster tree of subjects according to the pairwise dissimilarity matrix among heart rate
dynamics using an information-based similarity index method. Dissimilarity matrix data were visualized and clustered by a generalized
association plot algorithm [58]. The bars on the left indicate the b-adrenergic receptor (b-AR) gene polymorphisms rs1801252 (green: homozygous
Ser49 carriers; blue: Gly16 allele carriers; red: unknown genotype), rs1042713 (green: homozygous Arg16 carriers; blue: Gly16 allele carriers) and
rs1042714 (green: homozygous Gln27 carriers; blue: Glu27 allele carriers).
doi:10.1371/journal.pone.0019232.g002
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Although substantial efforts have been made to link b1-AR
polymorphisms with cardiovascular function, studies have been
mixed in this regard. For example, b1-AR Ser49Gly polymorphism
was found to be associated with increased blood pressure and heart
rate [14,15] but data are inconsistent in our findings and other
reports [48,49]. Because we studied only one polymorphism in b1-
AR, further research is needed to identify other possible b1-AR
polymorphisms associated with HRV.
This study found that b2-AR Arg16Gly genotype was associated
with clusters based on acceleration/deceleration patterns of heart
rate. Although b2-AR is expressed in the heart at lower
concentrations than is the b1-AR subtype, it also expresses on
the presynaptic sympathetic nerve terminals and expresses
abundantly in vascular and bronchial smooth muscle. Therefore,
changes in b2-AR function may not only alter sympathetic activity
[50], but also respiration and vascular responses [51,52]. It can be
reasonable to speculate that these factors have influences in HRV.
Of note, the association between b2-AR Arg16Gly polymorphism
and heart rate fluctuation patterns may simply reflect a functional
genetic component nearby due to linkage disequilibrium and
warrants future genetic research targeting on this region.
The non-randomness index was developed initially as a
nonlinear HRV index [17] and its connection with other
traditional HRV indices needs to be explored. Though the non-
randomness index was weakly associated with HRV indices (r-
square,0.1; Table S3), it did correlate negatively with HF power
and positively with the LF/HF ratio, suggesting that the non-
randomness index is a marker related to sympathovagal balance.
Our findings of lower non-randomness index and LF% seen in
homozygous b2-AR Arg16 carriers are in line with prior studies
showing that the b2-AR Arg16 polymorphism is associated with
lower sympathetic activity, manifested as lower blood pressure
[53,54], lower plasma norepinephrine [54,55], and enhanced
agonist-mediated desensitization in the vasculature [56].
Strength of this work include a larger sample size, matched
gender distribution, and long recording of ECG signals using a
Holter recorder, compared to prior genetic association study of
HRV. Several limitations influence the interpretation of the
findings presented in this study. First, we are unable to repeat
findings of spectral HRV indices seen in a smaller male sample
[11]. This may be due to different gender distributions [57] and
means of ECG recording. Twenty-four hour Holter recording
could validate and reinforce the association of b-AR genetic
polymorphism with HRV seen in this study. Second, we were
unable to evaluate the correlation of the non-randomness index
with other commonly used sympathetic indicators, such as blood
pressure or plasma catecholamine levels. Third, our findings are
based on a healthy population and may not be generalizable to
medically ill patients, such as those with cardiovascular diseases.
The cross-sectional nature of our study also limited us examining
the age modification of the effect of b-AR receptor polymorphism
on autonomic function.
In conclusion, this study shows that a bottom-up, categorization
approach combining the IBS method and hierarchical cluster
analysis can detect subgroups of subjects based on phenotypes that
are associated with b2-AR gene polymorphisms. Further research
should aim to identify the physiological mechanisms underlying
these findings.
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